Your search matched 20 results
This edition of Medical-Science Moments begins with a wrap up of the top 10 science stories of 2018, as designated by Science News.
This edition of Medical-Science Moments includes: FDA’s recent crackdown on dietary supplements, J&J leadership on drug pricing disclosure and human microbiome research.
This edition of Medical Science Moments features highlights from the recent ASCO conference.
This edition of Medical Science Moments features research and other news on: CRISPR gene editing to treat human diseases; New approvals for CAR-T cell therapies; Stem cell therapy for heart failure
This edition has some good news about exercise, use of social media to monitor drug adverse effects, questions about credibility of early trial results, and some quick bits from CRISPR to obesity.
Teachable moments are when we’re most open to new ideas.
An update on the latest developments in Washington critical to Pharma leaders.
Today, doctors are feeling more pressured than ever to keep up with the growing demands of their career, and it’s taking a toll on their mental health.
Live from eyeforpharma Philadelphia 2019— a look at "Field Force Effectiveness in a “Many-to-Many” World".
In a highly anticipated decision, the Food and Drug Administration (FDA) last week cleared Alzheimer’s disease drug aducanumab on an accelerated, conditional approval program.
But today, Dave Sonderman, Chief Creative Officer at GSW, joined two experts on the art and science of empathy to talk about how that deeper understanding can change the future healthcare.
Healthcare and people: both are capable of amazing things.
Stressed About Your Diet? | Blog
For those of us squarely in the mid-latitudes of the northern hemisphere, fall is upon us, and that means more than PSLs to our Innovation team—trendspotting season is well underway.
Snow-much to discuss! | Blog
Just when we thought spring might be around the corner, a second nor’easter comes along (no need to be smug West Coast readers, we know you’ve got the sun).
Over dinner last night, some colleagues compared their families by level of device and technology addiction.
In healthcare alone virtual reality and augmented reality is expected to be a $5.1 Billion industry by 2025 with a CAGR of +53% over the next five years.
This month, we’ve seen a flurry of activity that confirms Washington will be focused on drug pricing this summer, and it’s coming from all directions: Congress, the Biden Administration, and Courts.
Not your typical geotag for pharmaceutical innovation, Jackson Hole and its most prominent biologist, Paul Cox, may turn decades’ and billions of dollars’ worth of Alzheimer’s research on its head.
Talk Healthy to Me | Perspectives
There has never been a better time to talk about Voice.
Our favorite fall TV shows are finally starting back up and we’ve DVRed (yes, it’s a verb people) the Sanders-Klobuchar versus Graham-Cassidy Town Hall debate on CNN.